Jan 19, 2021 | Commentary
After nearly a year of facing the challenging mystery of the COVID-19 pandemic, it appears relief is on the horizon. On December 11 and 18, the FDA granted emergency use authorization to the two mRNA COVID-19 vaccines developed by Pfizer-BioNTech and Moderna. (more…)
Jan 12, 2021 | News, Value-Based Drug Management
On behalf of everyone at Chelko and our clients, we would like to recognize the efforts of Lucia Vescera and Kelly Prymicz on National Pharmacist Day. (more…)
Jan 8, 2021 | Legislative Updates
On Jan. 7, 2021, the Equal Employment Opportunity Commission (EEOC) issued two proposed rules on wellness programs under the Americans with Disabilities Act (ADA) and the Genetic Information Non-Discrimination Act (GINA). Read more…
Jan 4, 2021 | Legislative Updates
Employers must comply with numerous reporting and disclosure requirements throughout the year in connection with their group health plans. This Compliance Overview explains key 2021 compliance deadlines for employer-sponsored group health plans. It also outlines group health plan notices that employers must provide each year. Read more…